David J. Schlanger
At a glance: David J. Schlanger is Chair at Progyny (PGNY). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $1.3M. On file: 0 purchase lines ($0) and 3 sale lines ($7.1M).
Disclosed holdings: about $8.6M of PGNY stock: 238,462 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 13, 2026 close of $36.18. This counts only PGNY shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Chair at Progyny, Inc. (PGNY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Every purchase since 2024
From the SEC's insider data sets: each open-market buy by David J. Schlanger, matched to how the stock did over the next 90 days against the S&P 500.
1 of 1 buy beat the S&P 500 (100%), median +53.6% vs. the index. Small sample: treat with care. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| PGNY | Dec 26, 2024 | +53.6% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 12SEC | PGNYProgyny, Inc. | Sell Plan | 35,392238,462 held (−13%) | $35.36 | $1.3M | +2.3% |
| Nov 9SEC | PGNYProgyny, Inc. | Sell Plan | 3,400238,462 held (−1%) | $35.22 | $120K | +2.7% |
| Nov 9SEC | PGNYProgyny, Inc. | Sell Plan | 161,208238,462 held (−40%) | $35.73 | $5.8M | +1.3% |
- Sell
Chair David J Schlanger sold $1.3M of PGNY at $35.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair David J Schlanger sold $120K of PGNY at $35.22 — pre-scheduled 10b5-1 plan sale.
- Sell
Chair David J Schlanger sold $5.8M of PGNY at $35.73 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
Follow David J. Schlanger
Get one email when David J. Schlanger files a new purchase or sale. Free.
At most one email a day about David J. Schlanger, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.